Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Clostridium is a large genus of obligate anaerobic, Gram-positive, rod-shaped, spore-forming bacteria belonging to the phylum Firmicutes[1][2][3][4]. Clostridium species inhabit soil, the intestines of animals and humans, and include both pathogenic and non-pathogenic variants. Some species are medically significant due to their ability to produce potent toxins which cause diseases such as botulism (C. botulinum), tetanus (C. tetani), gas gangrene (C. perfringens), and antibiotic-associated diarrhea (formerly Clostridium difficile, now Clostridioides difficile)[1][2][5]. The group is taxonomically diverse; the genus has been subject to multiple taxonomic revisions, and many former members have been reclassified into new genera as molecular techniques have refined bacterial phylogeny[1][2]. Key points: - "Clostridium" is not a single molecular target but a classification of bacteria with highly variable pathogenic profiles. - Molecular and drug targeting focuses on individual Clostridium species or their toxins, not on the genus as a whole. - Species within the genus are of high clinical importance due to their roles in severe infectious diseases[4][5]. For any structured information about therapeutic targets, it is necessary to specify the species (e.g., Clostridium botulinum) or the toxin (e.g., botulinum toxin) rather than the genus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clostridium.